Versant Venture Management as of Sept. 30, 2024
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 6 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 36.8 | $23M | 499k | 46.98 | |
| Contineum Therapeutics Common Stock (CTNM) | 27.6 | $18M | 918k | 19.14 | |
| Repare Therapeutics Common Stock (RPTX) | 14.3 | $9.1M | 2.6M | 3.44 | |
| Skye Bioscience Common Stock (SKYE) | 12.3 | $7.9M | 2.0M | 3.91 | |
| Adverum Biotechnologies Common Stock | 5.6 | $3.6M | 507k | 7.02 | |
| Gritstone Oncology Common Stock (GRTS) | 3.2 | $2.1M | 3.6M | 0.58 |
